Sunday, October 11, 2026

USD/CNH Jumps By 3% In The Last 21 Sessions

USD/CNH Jumps By 3% In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 3.13% for the last 21 sessions. At 05:06 EST on Monday, 5 June, USD/CNH (USDCNH) is $7.13.

USD/CNH's yearly highs and lows, it's 0.492% up from its 52-week low and 0.006% down from its 52-week high.

News about

  • Usd/jpy bulls trace firmer yields above 140.00, US pmis, Japan GDP eyed. According to FXStreet on Monday, 5 June, "USD/JPY clings to mild gains around 140.20 as it cheers upbeat Treasury bond yields, as well as the firmer US Dollar to propel the USD/JPY prices. ", "It's worth noting, however, that the hawkish concerns about the Bank of Japan (BoJ) officials and optimism about the US debt ceiling deal, as well as US credit rating, prod the USD/JPY bulls. "
  • Usd/jpy price analysis: ready to fly above 140.40 as upbeat US NFP accelerates hawkish fed bets. According to FXStreet on Monday, 5 June, "The USD/JPY pair has shifted its auction comfortably above the crucial resistance of 140.00 in the Asian session. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com